Introduction
A previous study of the health of men from the United Kingdom who took part in the United Kingdom's programme of atmospheric nuclear weapon tests in Australia and the Pacific Ocean during the 1950s and 1960s showed that the total mortality and the mortality from all neoplasms combined were both almost identical in test participants and in a matched control group.' 2 The mortality from leukaemia and from multiple myeloma was, however, substantially higher in the test participants than in controls (though not much greater than would be expected from comparison with national data), while the mortality from the two diseases most closely related to smoking was significantly lower in the test participants than in the controls. Three hypotheses were, therefore, suggested which could be tested only by further observationsnamely, that (a) test participation caused small hazards of leukaemia (excluding chronic lymphatic leukaemia) and multiple myeloma; (b) test participation did not cause a detectable hazard of any other cancer or of any other disease that has an appreciable death rate; and (c) that participants smoked less than other similarly employed men. The men have now been followed up for a further seven years to see whether these hypotheses could be confirmed and to examine the long term effects of test participation. The 8444 (40%) in the Royal Air Force, and 816 (4%) in the civilian workforce. The men are those that were studied previously, plus a few additional participants found in archival material but excluding 1503 men with no more likelihood than members of the general public of having been exposed to radiation from the tests (usually because they had left the test locations before the first detonation).
A control group of 22333 men who had not participated in the tests was also identified from Ministry of Defence archives. Controls for servicemen were chosen from other servicemen who had served in tropical or subtropical areas at the time of the tests. Controls for the men in the Royal Navy and for officers in the army and the Royal Air Force were chosen from contemporary lists of men serving in appropriate ships or units; for airmen and soldiers no contemporary lists were available and so an individually matched control was selected for each man directly from neighbouring service records in the service records offices.2 Individually matched controls for civilians were selected from other employees of the Atomic Weapons Establishment at the time of the tests. 2 The distributions of test participants and controls by service, rank, year of birth, year of enlistment or employment, and year of discharge or termination of employment were closely similar.
In our previous report lists of names of test participants were also requested from organisations that had compiled lists independently of sources in the Ministry of Defence's archival material; these participants were studied separately. In the present study names of further "independent respondents" were sought from these organisations; for all those who had not been included in the main study information was requested from the Ministry of Defence to establish whether they had, in fact, participated. On the basis of this information it was estimated that 85% of all participants had been included in the main study. of soldiers and civilians, were entered at the time of the overseas visit which led to their inclusion in the control group; soldier controls were entered into the study on the date of termination of their reserve liability, and civilian controls were entered into the study on the date that the participant with whom they were matched took part in his first test. Men were removed from the study on the date of their death, emigration, or 85th birthday or on 31 December 1990, whichever was the earliest. For the analyses of cancer incidence men were also removed on the date of cancer registration when appropriate. Standardised mortality ratios were calculated from national mortality statistics in five year age groups for single calendar years. Two sided tests were used for calculating the significance of standardised mortality ratios, and 95% confidence intervals are shown in the usual way.
To compare mortality in participants and controls the data were stratified into five year age and calendar year groups by service and by rank. Relative risks were estimated by maximum likelihood. We were specifically interested in testing the hypothesis that mortality and the incidence ofcancer were greater among participants than controls so, as in the previous report,1 one sided tests (in the direction of the observed difference) were used to calculate the significance of relative risks with corresponding 90% confidence intervals. and poisoning the standardised mortality ratio in participants and the relative risk were initially above 1; standardised mortality ratios were subsequently above 1 in both groups and the relative risk was 100 precisely. Finally, for lung cancer, for which the relative risk had previously been significantly low for cancer incidence and for mortality when the first 10 years of observation were omitted, the relative risk was not significantly different from unity in either time period.
Results

STUDY OF HYPOTHESES GENERATED BY PREVIOUS REPORT
For the broad groups of causes the relative risks in participants versus controls were similar in both periods, having values of 0-96 and 0-96 respectively for all neoplasms and 1 01 and 0 99 for all causes. Similar relative risks were obtained for the cancers shown in table I when the analysis was repeated using cancer incidence.3
LONG TERM EFFECT OF TEST PARTICIPATION ON HEALTH
Mortality in test participants for different times since the initial participation is shown in table II. For non-neoplastic diseases the effect of selecting healthy men for participation was pronounced in the first 10 years (standardised mortality ratio 0 54) and then decreased progressively; for neoplasms the initial effect of selection was weaker (standardised mortality ratio 0 72) and there was little trend after 10 years, although standardised mortality ratios remained low for the entire study. For accidents and violence the standardised mortality ratio was initially high and then diminished as the men changed from service to civilian life.
In many studies of the effects of radiation increases in risk are clearest more than 10 years after exposure for cancers other than leukaemia.5 Therefore to avoid the time when the effect of selecting healthy men is greatest, and to maximise the chance of detecting a hazard that was not apparent in our earlier report, we concentrated on the period more than 10 years after initial participation. During this time the standardised mortality ratios from all causes, all neoplasms, and all other diseases were below unity in participants, but the standardised mortality ratio of accidents and violence was above unity ( specific for social class (rates for men in social class I for officers and employees in social class I and rates for men in social class III (manual and non-manual combined) for other servicemen and employees) they were slightly higher but, with the exception of accidents and violence, were still less than unity. For these broad groups of causes little difference was observed between the participants and controls, with all relative risks close to and not significantly different from unity. In the previous report mortality was examined in independent respondents who had been identified before 31 March 1986 and who were not in the main study. Table VI shows the mortality in the same group separately for the period up to 31 March 1986 and for 1 April 1986 to 31 December 1990. In the earlier period mortality from all causes, all neoplasms, and leukaemia were all substantially raised (standardised mortality ratios for all causes 2-05 (1-61 to 2-57; all neoplasms 5418 (3 83 to 6 85); and leukaemia 10-66 (2-87 to 26-95)). This was to be expected as independent respondents were mainly the men who had contacted the organisation that had given us the man's name or men whose relatives had contacted the organisation. They thus form a highly selected group, and their mortality up to the end of the period of enrolment was unlikely to be representative of participants as a whole. In the period after enrolment ceased, however, mortality from all causes was close to that expected (standardised mortality ratio 1 17 (0-69 to 1-85)); mortality from all neoplasms was less than expected (standardised mortality ratio 0.81 (0-22 to 2 07)) and there were no deaths from leukaemia.
Discussion GENERAL CONSIDERATIONS
Despite extensive efforts, the present study includes only an estimated 85% of participants. This raises the possibility of differential selection. In this analysis the period of additional follow up, providing 43% of deaths, is almost all prospective as nearly all the men were identified at the beginning of the period and their inclusion is unrelated to any subsequent diseases. In the previous report mortaiity among independent respondents omitted from the main study was high. During prospective follow up after enrolment ceased, however, standardised mortality ratio for all causes of death among independent respondents was close to unity and the ratio for cancer was similar to that for participants included in the study (table VI) .
Harmful effects associated with the tests could be obscured by including among the participants men who were only peripherally involved. Therefore men who had no more potential for radiation exposure from the tests than the general public have been excluded from the main group, although their follow up has continued separately.3 A harmful effect of participating in the tests could also be diluted by including the years immediately after the tests, shortly after the men had been selected as fit and healthy. Therefore, with the exception of leukaemia, which has been observed in excess in irradiated populations within five years of exposure, we have eliminated the 10 years after initial test participation, although results for the entire period offollow up are available elsewhere.3
LEIJRAEMIA AND MULTIPLE MYELOMA
The hypothesis that test participation might have caused small hazards of leukaemia (other than chronic lymphatic leukaemia) and multiple myeloma was based on high relative risks in participants compared with controls up to the end of 1983 (table I) . The size and importance of both excesses, however, were principally due to the scarcity of cases in the control group and may have been due to chance. The additional follow up has supported this alternative hypothesis. For both diseases standardised mortality ratios in controls were close to unity for and greater than those in participants. For multiple myeloma the standardised mortality ratio for the period more than 10 years after initial test participation was below unity (table IV) and neither the incidence of nor the mortality from the disease is exceptionally high in participants compared with controls. The excess of multiple myeloma in participants compared with controls reported previously therefore seems likely to have been a chance finding.
Interpretation of the results for leukaemia is less straightforward. We anticipated that any risk would most likely be concentrated between two and 25 years after the initial participation. During this time the standardised mortality ratio was slightly greater than unity and the incidence of and mortality from leukaemia were both significantly greater in participants than controls (table IV) . Furthermore, a report on Royal New Zealand Navy staff participating in the Grapple operations showed a significant increase in mortality from leukaemia, compared with national rates (four deaths v 0-6 expected, p=0 003) and with a control group of Royal New Zealand Navy staff who did not attend the tests (relative risk 5 58 (1 04 to 41 6) ).
This evidence is, however, weak. Firstly, for the entire follow up period the standardised mortality ratio for leukaemia among participants was 1 -00 (table IV) . Secondly, continued observation has shown that the low standardised mortality ratio for the controls up to 1983 was atypical because the ratio was subsequently close to unity (table I) . Thirdly, the highest standardised mortality ratio was found in men who were not present at a major operation, who were not in groups identified by the Ministry of Defence as liable to exposure to radiation, and who were not employed by the Atomic Weapons Establishment or directly involved in the minor trials at Maralinga (those in whom undocumented inhalation or ingestion, if any, is most likely to have occurred) (table V). Also risk did not increase with increasing recorded dose.3 The recorded doses were, moreover, very small and are estimated to cause a less than 50% chance ofdeveloping one fatal case in the entire cohort.7-9 Fourtly, the excess in Royal New Zealand Navy staff is difficult to attribute to the tests. According to the Ministry of Defence, the ships of the Royal New Zealand Navy were at least 40 km from the detonations and so would not have been irradiated directly. Both ships visited Christmas Island after the tests, but this seems unlikely to have caused any increase when little or none was seen in staff from the United Kingdom serving at Christmas Island (16 deaths observed and 14 30 expected for all participants in the Grapple series from the United Kingdom). Three of the four deaths in the Royal New Zealand Navy occurred more than 25 years after the tests, which would not be expected if they were caused by irradiation at the time ofthe tests.
On balance, the excess of leukaemia in participants compared with controls seems likely to be a chance finding due to an exceptionally low rate in the controls in the early period. However, the possibility that participants experienced some small risk of developing leukaemia in the first 25 years (standardised mortality ratio 1 23) cannot be ruled out, although, if they did there is no evident explanation for it.
OTHER DISEASES
The hypothesis that participation in tests did not cause a detectable hazard of other cancers or of other diseases with appreciable mortality is supported by the further data. For all neoplasms and all causes, mortality is again almost identical in participants and controls in the extended period (relative risks 0-96 and 0 99 respectively; table I). The standardised mortality ratios for these diseases are slightly higher in the extended period than before as the effect of selecting healthy workers diminished.
When many diseases are examined some differences will occur by chance. In table I, for example, high rates from prostate and kidney cancers in the controls and the significant differences between the participants and controls up to 1983 subsequently disappeared. We examined 27 cancer sites. As one sided tests have been used to compare the mortality of participants and controls three significant differences would occur Clinical implications * A study published in 1988 which compared the mortality and incidence of cancer in men who participated in nuclear weapon tests with those in a control group suggested that the participants might have had a greater risk of leukaemia and myelomatosis but not of other diseases * This study extended the follow up for seven years and found that mortality from all causes and from all neoplasms was similar in both groups and less than expected from national rates * Compared with national rates the only notable excess of deaths was from accidents and violence, which occurred equally in both groups * In the past seven years mortality from leukaemia and myelomatosis was lower in participants than in controls * Participation in the tests had no detectable effect on expectation of life or on the incidence of cancer but the possibility of a small risk of leukaemia in the 25 years after the tests cannot be excluded by chance on average. In fact four have occurred, including one for leukaemia. The other three are increases in bladder cancer and deficits in lung cancer and cancers of the mouth, tongue, and pharynx (mortality analyses) (table IV) and increases in cancers of liver and bladder and a deficit ofnon-melanoma skin cancer (incidence analyses). For bladder cancer the data are suggestive of a chance effect as the difference between participants and controls is greater for mortality (relative risk 2 69) than for incidence (relative risk 1-45) and the standardised mortality ratio in the controls is very low (0 39). For liver cancer the raised relative risk in the incidence analysis may also be partly due to a low rate among the controls, as suggested by the mortality analysis (standardised mortality ratio 0 53). Moreover, examination of the detailed description on the death certificates and cancer registrations showed that several of the so-called liver cancers should not have been described as such; the numbers of definite primary liver cancers in the two groups were respectively 10 and four. This difference is not significant (p=009) and could well be due to chance. A raised risk of liver cancer was also observed in the test participants exposed to no more radiation than the general public (standardised mortality ratio 4 47). 3 This suggests that any increase in liver cancer not due to chance was unconnected with exposure to radiation.
SMOKING HABITS OF TEST PARTICIPANTS COMPARED WITH CONTROLS
The hypothesis that test participants smoked less than controls is not supported by the additional data. In the extended follow up rates of lung cancer were similar in the two groups, and for bronchitis, emphysema, and chronic obstructive lung disease rates in the participants exceeded those in controls (table I) . Previous results suggesting this hypothesis were probably chance observations, and it would be inappropriate to consider smoking related diseases separately from other diseases in examining the effect oftest participation on mortality or cancer incidence. CONCLUSION Participation in nuclear weapon tests has not had a detectable effect on participants' expectation of life or on their risk of developing cancer or other fatal diseases. The greater relative risks of leukaemia and of multiple myeloma that were observed previously in the test participants compared with the controls were succeeded by lower relative risks; the initial findings are likely to be due to the chance occurrence of low rates in the control group. The possibility that test participants experienced a small excess risk of leukaemia in the first 25 years after participation cannot be ruled out; but it is difficult to attribute it to any known cause as the risk was not concentrated in those known to have been exposed to radiation, those involved in any particular operation, or those employed in any particular type of job. The other significant differences that we observed previously between the morbidity and the mortality of the participants and the controls, including a deficiency of smoking related diseases and two other types of cancer, disappeared in the extended follow up. Other differences were found in their place, as was to be expected when many diseases were studied. All seem likely to have been chance findings.
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